These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17437583)

  • 1. Electrical cardioversion for AF-the state of the art.
    Gall NP; Murgatroyd FD
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):554-67. PubMed ID: 17437583
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Shelton R
    Eur Heart J; 2004 Dec; 25(23):2174; author reply 2174-5. PubMed ID: 15571844
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of angiotensin-converting enzyme inhibitors in the maintenance of sinus rythm after conversion of arterial fibrillation].
    Grecu M; Olteanu RO; Olteanu SS; Georgescu CA
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):607-12. PubMed ID: 18293688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
    Doğan A; Akçay S
    Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation.
    Holmqvist F; Stridh M; Waktare JE; Sörnmo L; Olsson SB; Meurling CJ
    Eur Heart J; 2006 Sep; 27(18):2201-7. PubMed ID: 16956916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation: new theories, emerging treatments.
    Johnson J; Napier KT
    JAAPA; 2005 Jun; 18(6):36-41; quiz 43-4. PubMed ID: 15977854
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Med Clin North Am; 2008 Jan; 92(1):101-20, xi. PubMed ID: 18061000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Cardiol Clin; 2009 Feb; 27(1):95-107, ix. PubMed ID: 19111767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is cardioversion always needed in atrial fibrillation?].
    Toivonen L
    Duodecim; 2003; 119(3):171-2. PubMed ID: 12650014
    [No Abstract]   [Full Text] [Related]  

  • 10. Findings suggest revised atrial fibrillation approach.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(1):7-9. PubMed ID: 12762304
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic atrial fibrillation in adults: direct current cardioversion or medical cardioversion].
    Fradi I; Mokaddem A; Selmi K; Boujnah MR
    Tunis Med; 2006 Dec; 84(12):772-6. PubMed ID: 17288278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
    Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The therapeutic efficiency of complex-ACE inhibitor (perindopril) and traditional antiarrhythmic-treatment for prevention atrial fibrillation paroxysms after successful electric cardio version].
    Abuladze GV; Dzhindzholiia NR; Narsiia EV; Dzhincharadze BZ; Kadzhaia TZ
    Georgian Med News; 2008 Feb; (155):17-9. PubMed ID: 18401049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
    Aronow WS
    Cardiol Rev; 2008; 16(4):181-8. PubMed ID: 18562808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
    Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
    Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for external cardioversion/defibrillation.
    Burton ME; Leon AR
    Heart Dis Stroke; 1994; 3(6):322-5. PubMed ID: 7850151
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardioversion threshold, IRAF and beyond.
    Merckx KL; Tieleman RG; Crijns HJ
    Eur Heart J; 2004 Jun; 25(11):997. PubMed ID: 15172478
    [No Abstract]   [Full Text] [Related]  

  • 19. [The electrical cardioversion of atrial fibrillation after 50 years since initial application: contemporary knowledge].
    Gilewski W; Sinkiewicz W
    Kardiol Pol; 2013; 71(7):757-63. PubMed ID: 23907913
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of atrial fibrillation--Part 1.
    Aronow WS
    Compr Ther; 2008; 34(3-4):126-33. PubMed ID: 19137753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.